News
- Vir Biotechnology, Inc. will begin a study of VIR-2218 + VIR-3434 in Subjects With Chronic Hepatitis B Virus Infection (MARCH)
- The company Walvax Biotechnology Co., Ltd is commencing recruitment for the clinical study to evaluate the protective Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate
- The research company Tilman S.A is conducting the clinical trial to evaluate the efficacy and safety of NASAFYTOL® on COVID-19 positive hospitalized patients.
- Erasmus Medical Center is starting a new clinical trial of Balloon vs. Self Expanding Transcatheter Valve for Degenerated Bioprosthesis.
- Aarhus University Hospital is about to start an ALLTogether study of Pharmacokinetics and Immunogenicity of the First Doses of PEG-Asparaginase.
- Veru Inc starts an Open-Label, Proof-of-Concept and Dose Finding Phase 1b/2 Study of VERU-100 in Men With Advanced Prostate Cancer.
- Weill Medical College of Cornell University is about to start a Phase 2, Open-Label, Single-Arm Study of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma.
- BioFactura Australia Pty Ltd started a new bioequivalence Phase I Study of BFI-751 Compared With EU-STELARA® and US-STELARA® in Healthy Adult Volunteers.
- A Study of MRG004A in Patients With Tissue Factor Positive Advanced or Metastatic Solid Tumors.
- The company ImmunityBio, Inc is commencing recruitment for the clinical trial of the COVID-19 Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines.
- The company Atreca, Inc is enrolling patients into the clinical trial investigating First-in-Human Dose Escalation Trial of ATRC-101 in Adults With Advanced Solid Malignancies.
- The research company Atreca, Inc is conducting the clinical trial First-in-Human Dose Escalation Trial of ATRC-101 in Adults With Advanced Solid Malignancies.
- Aelix Therapeutics started a study of HIV-1 Vaccines MVA.HTI and ChAdOx1.HTI With TLR7 Agonist Vesatolimod (GS-9620) in Early Treated HIV-1 Infection.
- Aelix Therapeutics is recruiting patients for the clinical trial of Safety, Tolerability and Immunogenicity of MVA.HTI and ChAdOx1.HTI With Vesatolimod in HIV-1 Positive Patients (AELIX-003).
- A HIV/AIDS clinical trial begins in China.
- Navigen, Inc started a new clinical trial of A Phase Ia Clinical Study of HIV Entry Inhibitor CPT31: Single Ascending Dose Study of Safety, Tolerability, Immunogenicity, and Pharmacokinetics in Healthy Adults.
- University of California started a new double-blinded, Placebo-controlled, Clinical Trial of Insulin-sensitizing, Anti-inflammatory and Anti-oxidant Activities of Astaxanthin in Insulin-resistant Subjects.
- A research institute in India conducts a clinical trial in patients suffering from osteoarthritis of knee joint.
- A research institute in Paraguay conducts a clinical trial of Efficacy of Ivermectin in Outpatients With Non-severe COVID-19: A Randomized Controlled Trial.
- A research institute in United States conducts a clinical trial of Pilot Study of 89Zr Panitumumab in Pancreas Cancer.
- A Clinical Trial of PRAX-114 in Participants With Major Depressive Disorder
- A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B Infection
- Assessment of the Impact of Oral Intervention With Cetylpyridinium Chloride to Decrease SARS-CoV-2 Viral Load in Patients With COVID-19
- Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients
- Antidepressant Effects of TS-161 in Treatment-Resistant Depression
Clinical Research News
今後の臨床試験
-
Nicholas ButowskiSiren Biotechnologyまだ募集していません神経膠腫 | 脳腫瘍 | 再発性の高悪性度神経膠腫アメリカ
-
State University of New York at Buffaloまだ募集していません
-
Poitiers University Hospitalまだ募集していません
-
Assistance Publique - Hôpitaux de Parisまだ募集していません
-
University of California, Irvine募集脳腫瘍 | 中枢神経系がん | 神経系がん | 脳癌転移性アメリカ
-
Guangdong Raynovent Biotech Co., Ltdまだ募集していません
-
The Hong Kong Polytechnic UniversityWu Jieh Yee Charitable Foundation募集
-
Shanghai General Hospital, Shanghai Jiao Tong University...まだ募集していません
-
Sun Yat-sen Universityまだ募集していません禁煙 | AIエージェント | Early-Stage Cancer
-
Affiliated Hospital of Nantong Universityまだ募集していません
-
AIMEDBIOBoehringer Ingelheimまだ募集していません固形腫瘍フランス, 日本, 韓国, アメリカ, オーストラリア
